University of Vermont

The University of Vermont Cancer Center

Protocol Review Committee

Committees

Protocol Review and Monitoring Committee

The membership of the Protocol Review and Monitoring Committee (PRMC) has been designed to provide broad representation from the various oncology subspecialties, including community oncology, and support areas critical to the success of a clinical research enterprise. This broad representation is necessary to provide high quality and thorough protocol review. All members of the PRMC are full voting members. The Co-Directors of the Cancer Center are ex officio members. The committee meets monthly. See a detailed schedule of committee meeting dates.

 
Name/Email Title/Area of Expertise Phone Information
H. James Wallace, M.D.
Protocol Review and Monitoring Committee Chair;
Associate Professor
Radiation Oncology
(802) 847-3506  
Steven Ades, M.D. Associate Professor
Medical Oncology
(802) 656-5451 Bio
Christopher Anker, M.D. Assistant Professor
Radiation Oncology
(802) 847- 3506  
George Atweh, M.D.

Professor
Hematology Oncology

(802) 847-8400  
Rob Cade, Pharm.D. Oncology Pharmacist (802) 847-5577  
Kim Dittus, M.D., Ph.D.
Assistant Professor
Medical Oncology
(802) 656-5470 Bio
Mark Evans, Ph.D.
Assistant Professor
Pathology
(802) 656-3628 Bio
Edmund Folefac, M.D.

Assistant Professor
Hematology Oncology

(802) 656-5487  
Alan Howe, Ph.D.

Professor
Pharmacology

(802) 656-9521  
Michael Lewis, M.D.
Associate Professor
Pathology
(802) 847-3015 Bio
Shelly Naud, Ph.D.
Researcher Analyst
Biostatistics
(802) 656-3822  
Scott Perrapato, D.O.
Associate Professor
Urology
(802) 847-2884 Bio
Michelle Sowden, D.O.
Assistant Professor
Surgical Oncology
(802) 656-5880 Bio
Karen Wilson, C.C.R.P.
Clinical Trials Supervisor, UVM Cancer Center (802) 656-4101  

Clinical Research Oversight Committee

The Clinical Research Oversight Committee (CROC) was a senior leadership committee charged with the responsibility for Data and Safety Monitoring. All clinical trials require monitoring, which is performed on a regular basis and is commensurate with the risk and size of the trial. The committee met quarterly. The CROC will be replaced with a Data Safety and Monitoring Committee and will be announced mid-2016.

Last modified November 17 2015 02:27 PM